Trade LUNG stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Pulmonx Corporation (LUNG) is trading at US$1.76, down 2.22% today as of Oct 13, 16:00 EDT. The company has a market capitalisation of US$97.06M. Over the past 52 weeks, LUNG has traded between US$1.13 and US$2.89. On Syfe you can trade LUNG with $0 commission and add it to your watchlist.
| Previous close | US$1.80 |
|---|---|
| Market cap | US$97.06M |
| 52-week range | US$1.13 – US$2.89 |
| Volume | 498.41K |
| Exchange | US |
Pulmonx Corporation
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. It operates through the following geographical segments: United States, Europe, Middle East, Africa, Asia Pacific, and Other International. The company was founded by Rodney Perkins on December 26, 1995 and is headquartered in Redwood City, CA.
Year: 2020
Pulmonx Corporation (LUNG) stock is trading at US$1.76, -2.22% from the previous close of US$1.80.
The market cap for Pulmonx Corporation (LUNG) stock is approximately US$97.06M.
The 52-week high for Pulmonx Corporation (LUNG) stock is US$2.89.
The 52-week low for Pulmonx Corporation (LUNG) stock is US$1.13.
Pulmonx Corporation (LUNG) does not currently pay a dividend.
Stay on top of LUNG
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
